LT - PHARMACEUTICAL COMPOSITION COMPRISING A3 ADENOSINE RECEPTOR AGONIST (IB-MECA/CF-101) FOR TREATMENT OF PSORIASIS
EN - PHARMACEUTICAL COMPOSITION COMPRISING A3 ADENOSINE RECEPTOR AGONIST (IB-MECA/CF-101) FOR TREATMENT OF PSORIASIS
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/7076 |
|
|
|
A61P 17/06 |
|
European patent
| (11) |
Number of the document |
2475371 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
10763456.0 |
|
Date of filing the European patent application |
2010-09-06 |
| (97) |
Date of publication of the European application |
2012-07-18 |
| (45) |
Date of publication and mention of the grant of the patent |
2016-11-23
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/IL2010/000729 |
|
Date |
2010-09-06 |
PCT application publication
| (87) |
Number |
WO 2011/027348 |
|
Date |
2011-03-10 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
20075309 |
2009-09-06
|
IL |
Inventors
| (72) |
FISHMAN, Pnina, IL
|
Grantee
| (73) |
Can-Fite Biopharma Ltd.,
10 Bareket Street P.O. Box 7537, Petach Tikva 49170,
IL
|
Title
| (54) |
PHARMACEUTICAL COMPOSITION COMPRISING A3 ADENOSINE RECEPTOR AGONIST (IB-MECA/CF-101) FOR TREATMENT OF PSORIASIS |
| |
PHARMACEUTICAL COMPOSITION COMPRISING A3 ADENOSINE RECEPTOR AGONIST (IB-MECA/CF-101) FOR TREATMENT OF PSORIASIS |
